Ibaraki, Japan

Takashi Obara

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.5

ph-index = 1


Location History:

  • Ibaraki, JP (2013)
  • Tsukuba, JP (2017 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Takashi Obara

Introduction

Takashi Obara is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of four patents to his name, Obara's work has had a considerable impact on medical diagnostics.

Latest Patents

Obara's latest patents include a monoclonal antibody against apolipoprotein A-IV (APOA4) and an immunological measurement method. The first patent provides an anti-APOA4 monoclonal antibody or an antibody fragment capable of accurately measuring APOA4 in a specimen. This invention also includes a measurement method for immunologically measuring APOA4 using the antibody or its fragment, along with a kit for measuring APOA4 that contains the antibody or fragment. Another significant patent involves a method for detecting neurological diseases associated with cognitive impairment by measuring the EphA4 extracellular domain from a biological sample taken from a subject.

Career Highlights

Throughout his career, Takashi Obara has worked with prominent companies such as Eisai R&D Management Co., Ltd. and Unimatec Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Obara has collaborated with notable colleagues, including Yoko Ida and Emiko Yumoto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunology.

Conclusion

Takashi Obara's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…